1 - 10 of 81 articles
NIH Budget Up.—
The Administration asked Congress to approve more than $1 billion for the National Institutes of Health in the fiscal year starting July 1.
Congress last year appropriated $918 million for NIH, a record high, but $12 million under the budget...
"We may disagree about the scientific data, we may disagree about the practical problems, we may disagree about the side effects—but let us at least find out what it is we disagree about." This plea for clarity by Christian F. Borchgrevink, MD, of Oslo, Norway, summarized the mood and...
Drugs are very good—if you don't use them," Michael Schwartz, MD, of Glastrup Hospital in Copenhagen, told The Journal.
He reported to The International Symposium on Anticoagulants in Ischemie Heart Disease, the results of a four-year controlled study of anticoagulant therapy...
To determine the measurable value of long-term anticoagulant therapy after myocardial infarction, four physicians at the University of Oregon Medical School in Portland instituted a controlled double-blindfold study seven years ago.
That study is still in progress, and to date...
If a physician believes that anticoagulant therapy cannot ethically be withheld from a group of control patients, then he cannot participate in an adequately designed clinical trial, in the opinion of A. S. Douglas, MD, of the Royal Infirmary in Glasgow, Scotland.
"If we are to use long-term anticoagulant therapy in coronary heart disease, when shall we start the therapy? There is general agreement that this treatment is prophylactic and not curative. From the vast literature on this subject it seems that the overwhelming majority has settled for...
"Do anticoagulants make a difference? That's the question we're asking," Benjamin Manchester, MD, of George Washington University School of Medicine in Washington, DC, told The Journal.
On the basis of clinical experience and time, he has noted that 15-25% of those who survive an...
Scientific and empirical information exchanged at last month's Symposium on the Use of Anticoagulants, held in Miami Beach, dealt principally with these two questions: Should anticoagulant drugs be used in treating ischemic heart disease? How should a controlled study be administered to...
Read and print from thousands of top scholarly journals.
Continue with Facebook
Sign up with Google
Log in with Microsoft
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Sign Up Log In
To subscribe to email alerts, please log in first, or sign up for a DeepDyve account if you don’t already have one.
To get new article updates from a journal on your personalized homepage, please log in first, or sign up for a DeepDyve account if you don’t already have one.